Fingerprint
Dive into the research topics of 'Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vascular safety profile of new generation BCR-ABL tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia
Hélène Haguet, Jonathan Douxfils, François Mullier, Christian Chatelain, Carlos Graux, Jean-Michel Dogne
Research output: Contribution to journal › Article › peer-review